This image is not available for purchase in your country.

Entresto heart failure drug

Entresto heart failure drug

C038/7371

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

DR P. MARAZZI / SCIENCE PHOTO LIBRARY DR P. MARAZZI / SCIENCE PHOTO LIBRARY

Restrictions:

Editorial use only.

Caption

Entresto heart failure drug. Packaging for the combination drug sacubitril and valsarta, sold here under the brand name Entrasto, and developed and marketed by the Novartis pharmaceutical company. The drug sacubitril acts to inhibit the neprilysin enzyme, while the drug valsartan is an angiotensin receptor blocker (ARB). This combination drug was approved for use in 2015.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}